Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other
pharmaceutical manufacturers in Asia:
sales of 2.67 billion Japanese Yen [US$23.83 million]
Eu Biologics Co Ltd
of South Korea
(24.89 billion Korean Won [US$21.93 million]
of which 91%
was OCV), and
based in South Korea
(22.32 billion Korean Won [US$19.66 million]
During the year ended March of 2018, sales at
Hester Pharmaceuticals Limited were 1.36 billion Indian Rupees (US$19.59 million).
increase of 10.5%
versus 2017, when the company's sales were 1.23 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited
(and since 2013, sales have increased a total of 109%).
Sales of Large Animal Health Production saw an increase
that was more than double the company's growth rate: sales were up
23.6% in 2018, from
152.03 million Indian Rupees to 187.83 million Indian Rupees.